Related content

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data - oxybutynin versus propantheline versus placebo

By Larsson G.   Hallen B.   Nilvebrant L.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 990-998

Elsevier

Access to resources Recommend Favorite

Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status

By Toglia Marc   Ostergard Donald   Appell Rodney   Andoh Masakazu   Fakhoury Allam   Hussain Iqbal  

International Urogynecology Journal, Vol. 21, Iss. 7, 2010-07 ,pp. : 847-854

Springer Publishing Company

Access to resources Recommend Favorite

Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms

By Brubaker Linda   FitzGerald Mary  

International Urogynecology Journal, Vol. 18, Iss. 7, 2007-07 ,pp. : 737-741

Springer Publishing Company

Access to resources Recommend Favorite

Impact of stress urinary incontinence and overactive bladder on micturition patterns and health-related quality of life

By Oh Seung-June   Ku Ja  

International Urogynecology Journal, Vol. 18, Iss. 1, 2007-01 ,pp. : 65-71

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of female overactive bladder with urinary incontinence in Slovakia

By Svihra J.   Baska T.   Martin M.   Bushnell D.   Kliment J.   Luptak J.   Sopilko I.   Dusenka M.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 85-85

Elsevier

Access to resources Recommend Favorite